Focused Wealth Management, Inc Gilead Sciences, Inc. Transaction History

Focused Wealth Management, Inc

$746 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	BUY	$73.27 - $83.09 $293 - $332	4 Added 0.36%	1,114 $90,000
Q3 2023 Nov 01, 2023	BUY	$73.94 - $80.67 $369 - $403	5 Added 0.45%	1,110 $83,000
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $22,422 - $25,576	-295 Reduced 21.07%	1,105 $85,000
Q1 2023 Apr 13, 2023	SELL	$77.31 - $88.08 $9,354 - $10,657	-121 Reduced 7.96%	1,400 $116,000
Q4 2022 Jan 13, 2023	BUY	$62.32 - $89.47 $249 - $357	4 Added 0.26%	1,521 $0
Q3 2022 Oct 20, 2022	BUY	$59.54 - $68.01 $297 - $340	5 Added 0.33%	1,517 $94,000
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $692 - $780	-12 Reduced 0.79%	1,512 $93,000
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $347 - $435	6 Added 0.4%	1,524 $91,000
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $5,709 - $6,480	-88 Reduced 5.48%	1,518 $110,000
Q3 2021 Oct 12, 2021	BUY	$67.69 - $73.03 $1,556 - $1,679	23 Added 1.45%	1,606 $112,000
Q2 2021 Jul 15, 2021	BUY	$63.47 - $69.35 $380 - $416	6 Added 0.38%	1,583 $109,000
Q1 2021 May 03, 2021	SELL	$60.0 - $68.46 $5,760 - $6,572	-96 Reduced 5.74%	1,577 $102,000
Q4 2020 Feb 03, 2021	BUY	$56.65 - $64.55 $19,374 - $22,076	342 Added 25.69%	1,673 $97,000
Q3 2020 Oct 19, 2020	SELL	$62.1 - $78.08 $7,017 - $8,823	-113 Reduced 7.83%	1,331 $84,000
Q2 2020 Jul 24, 2020	BUY	$72.34 - $84.0 $32,842 - $38,136	454 Added 45.86%	1,444 $111,000
Q1 2020 May 06, 2020	SELL	$62.63 - $80.22 $23,235 - $29,761	-371 Reduced 27.26%	990 $74,000
Q4 2019 Jan 21, 2020	SELL	$61.62 - $67.78 $21,505 - $23,655	-349 Reduced 20.41%	1,361 $88,000
Q3 2019 Nov 06, 2019	SELL	$62.51 - $69.0 $2,875 - $3,174	-46 Reduced 2.62%	1,710 $108,000
Q2 2019 Jul 19, 2019	SELL	$61.87 - $69.38 $139,702 - $156,660	-2,258 Reduced 56.25%	1,756 $118,000
Q1 2019 May 03, 2019	SELL	$62.53 - $70.05 $409,884 - $459,177	-6,555 Reduced 62.02%	4,014 $261,000
Q4 2018 Jan 30, 2019	SELL	$60.54 - $79.0 $364,753 - $475,975	-6,025 Reduced 36.31%	10,569 $661,000
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $577,866 - $639,804	-8,107 Reduced 32.82%	16,594 $1.28 Million
Q2 2018 Aug 15, 2018	BUY	$64.88 - $75.68 $43,469 - $50,705	670 Added 2.79%	24,701 $1.75 Million
Q1 2018 May 07, 2018	BUY	$72.84 - $88.8 $74,223 - $90,487	1,019 Added 4.43%	24,031 $1.81 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $139,169 - $163,365	-1,956 Reduced 7.83%	23,012 $1.65 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $252,457 - $299,230	3,501 Added 16.31%	24,968 $2.02 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,467	21,467 $1.52 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.

Account